1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Pain in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckett, SR; Chapman, V; Finn, DP; Jhaveri, MD; Kendall, DA; Marsden, CA; Roe, CH | 1 |
| Agarwal, N; Bátkai, S; Bergmann, F; Friess, H; Giese, NA; Giese, T; Kuner, R; Laukert, T; Michalski, CW; Pacher, P; Sauliunaite, D; Su, Y | 1 |
| Ates, M; Brune, K; Gühring, H; Hamza, M; Kotalla, CE; Schuster, J | 1 |
| Mechoulam, R; Panikashvili, D; Shohami, E | 1 |
| Bountra, C; Clayton, N; Marshall, FH; O'Shaughnessy, CT | 1 |
| Eisen, A; Feigenbaum, JJ; Mechoulam, R; Seltzer, Z; Zeltser, R | 1 |
6 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Pain
| Article | Year |
|---|---|
Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cannabinoid Receptor Agonists; Disinfectants; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Escape Reaction; Excitatory Amino Acid Antagonists; Formaldehyde; Homocysteine; Immunohistochemistry; Male; Microinjections; Movement; Pain; Pain Measurement; Periaqueductal Gray; Piperidines; Proto-Oncogene Proteins c-fos; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Time Factors | 2003 |
Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis.
Topics: Acute Disease; Animals; Biopsy; Cannabinoid Receptor Modulators; Cannabinoids; Ceruletide; Dronabinol; Female; Gene Expression Regulation; Humans; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Pain; Pancreas; Pancreatitis; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2007 |
HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test.
Topics: Analgesics, Opioid; Animals; Cannabinoid Receptor Modulators; Cannabinoids; Dinoprostone; Dose-Response Relationship, Drug; Dronabinol; Injections, Spinal; Male; Mice; Mice, Inbred C57BL; Morphine; Pain; Pain Measurement; Receptors, Cannabinoid; Receptors, Drug | 2001 |
Cannabinoids and brain injury: therapeutic implications.
Topics: Animals; Arachidonic Acids; Brain; Brain Injuries; Cannabinoid Receptor Modulators; Cannabinoids; Clinical Trials, Phase III as Topic; Dronabinol; Endocannabinoids; Glycerides; Humans; Neuroprotective Agents; Pain; Polyunsaturated Alkamides; Rats | 2002 |
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
Topics: Acute Disease; Animals; Camphanes; Cannabinoids; Carrageenan; Dronabinol; Hypersensitivity; Indoles; Male; Morpholines; Neurogenic Inflammation; Nociceptors; Pain; Pyrazoles; Rats; Rats, Inbred Strains; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug | 2002 |
Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties.
Topics: Animals; Behavior, Animal; Body Weight; Copper; Dronabinol; Drug Interactions; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Nervous System Diseases; Pain; Pain Measurement; Rats; Receptors, N-Methyl-D-Aspartate | 1991 |